Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

This article explores the process of immune system aging, asking whether there is anything we can do to slow the aging clock ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Assistant Professor Anthony Tan, PhD student He Shan and Professor Antonio Bertoletti monitor the effectiveness of T-cell immunotherapy using their newly developed test ...

I've tossed my makeup wipes in favor of this long-lasting helper, and my face has never been softer — even in winter.

In today's demanding world, maintaining optimal health and well-being is more important than ever. Many men seek natur ...

The researchers utilized a Fra-2 transgenic mouse model that encompasses many of the features of systemic sclerosis in humans, including spontaneous systemic inflammation and fibrosis in the lungs, ...

The disease involves the activation of Th2 helper T cells and cytokines produced by these cells, including IL-4, IL-5 and IL-13. The researchers utilized a Fra-2 transgenic mouse model that ...

plasma cells, and T follicular helper cells, as well as IFNγ downstream activation and an increased dendritic cell maturation gene signature score. Peripheral pharmacodynamic effects aligned with the ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...